glp-1 news updates november 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 Pipeline Update: November 2025

has a lot to like

When subcutaneous fat decreases, the skin overlying that fat may tighten or appear smoother in some areasparticularly where fat loss is most pronounced

Hair loss has been reported by approximately 1 in 20 Wegovy users

Work with your doctor to create a plan that includes managing side effects, setting realistic goals and maintaining progress after stopping the medication

Choosing between GLP-1 and GLP-2 (GLP-3 is not a current option) depends entirely on your health goals and conditions: Choose GLP-1 If Youre Focused On: Blood sugar control and diabetes management Weight loss and appetite suppression Metabolic health optimization Cardiovascular risk reduction Overall metabolic syndrome improvement Choose GLP-2 If Youre Dealing With: Short bowel syndrome Inflammatory bowel disease Malabsorption issues Intestinal damage or injury Chronic gut inflammation Need for improved nutrient absorption Consider Medical Consultation Neither GLP-1 nor GLP-2 should be started without proper medical evaluation

BMI Between 30 and 35 Requires associated conditions such as uncontrolled hypertension or advanced stage chronic kidney disease